Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial

被引：0
|
作者：
Zubin Punthakee
Michael E. Miller
Debra L. Simmons
Matthew C. Riddle
Faramarz Ismail-Beigi
David J. Brillon
Richard M. Bergenstal
Peter J. Savage
Irene Hramiak
Joseph F. Largay
Ajay Sood
Hertzel C. Gerstein
机构：
[1] McMaster University,Department of Medicine
[2] Wake Forest University,Department of Biostatistical Sciences, Division of Public Health Sciences
[3] University of Utah,Division of Endocrinology, Department of Internal Medicine, School of Medicine
[4] VA Salt Lake City Health Care System,Division of Endocrinology, Diabetes & Clinical Nutrition
[5] Oregon Health & Science University,Department of Medicine
[6] Case Western Reserve University,Division of Endocrinology
[7] Cleveland VA Medical Center,National Institute of Diabetes and Digestive and Kidney Diseases
[8] Weill Cornell Medical College of Cornell University,Department of Medicine
[9] International Diabetes Center at Park Nicollet,Division of Endocrinology, Department of Medicine
[10] National Institutes of Health,undefined
[11] Western University,undefined
[12] University of North Carolina,undefined
[13] Louis Stokes VA Medical Center,undefined
来源：
Diabetologia | 2014年 / 57卷
关键词：
Intensive glucose lowering; Long-term glycaemic control; Post-intervention follow-up; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2030 / 2037
页数：7
相关论文
共 50 条
  • [1] Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial
    Punthakee, Zubin
    Miller, Michael E.
    Simmons, Debra L.
    Riddle, Matthew C.
    Ismail-Beigi, Faramarz
    Brillon, David J.
    Bergenstal, Richard M.
    Savage, Peter J.
    Hramiak, Irene
    Largay, Joseph F.
    Sood, Ajay
    Gerstein, Hertzel C.
    DIABETOLOGIA, 2014, 57 (10) : 2030 - 2037
  • [2] Intensive therapy of type 2 diabetes (ACCORD trial)
    Drake, John W.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2009, 76 (02) : 83 - 83
  • [3] Is an intensive glycaemic control beneficial in diabetes type 2?
    Rakowitz, Bettina
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (39) : 1940 - 1940
  • [4] Effects of Intensive Blood Pressure Control in the Management of Patients With Type 2 Diabetes Mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
    Mancia, Giuseppe
    CIRCULATION, 2010, 122 (08) : 847 - 849
  • [5] Intensive Risk Factor Management and Cardiovascular Autonomic Neuropathy in Type 2 Diabetes: The ACCORD Trial
    Tang, Yaling
    Shah, Hetal
    Bueno Junior, Carlos Roberto
    Sun, Xiuqin
    Mitri, Joanna
    Sambataro, Maria
    Sambado, Luisa
    Gerstein, Hertzel C.
    Fonseca, Vivian
    Doria, Alessandro
    Pop-Busui, Rodica
    DIABETES CARE, 2021, 44 (01) : 164 - 173
  • [6] Intensive Blood Pressure Control, Falls, and Fractures in Patients with Type 2 Diabetes: The ACCORD Trial
    Margolis, Karen L.
    Palermo, Lisa
    Vittinghoff, Eric
    Evans, Gregory W.
    Atkinson, Hal H.
    Hamilton, Bruce P.
    Josse, Robert G.
    O'Connor, Patrick J.
    Simmons, Debra L.
    Tiktin, Margaret
    Schwartz, Ann V.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 (12) : 1599 - 1606
  • [7] Intensive Blood Pressure Control, Falls, and Fractures in Patients with Type 2 Diabetes: The ACCORD Trial
    Karen L. Margolis
    Lisa Palermo
    Eric Vittinghoff
    Gregory W. Evans
    Hal H. Atkinson
    Bruce P. Hamilton
    Robert G. Josse
    Patrick J. O’Connor
    Debra L. Simmons
    Margaret Tiktin
    Ann V. Schwartz
    Journal of General Internal Medicine, 2014, 29 : 1599 - 1606
  • [8] Effects of Intensive Glucose Lowering in the Management of Patients With Type 2 Diabetes Mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
    Riddle, Matthew C.
    CIRCULATION, 2010, 122 (08) : 844 - 846
  • [9] INTENSIVE GLYCAEMIC CONTROL Hard end points are needed for intensive glycaemic control in patients with type 2 diabetes
    Yudkin, John S.
    Lipska, Kasia J.
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [10] Effects of intensive risk factor management on cardiovascular autonomic neuropathy in type 2 diabetes: findings from the ACCORD clinical trial
    Pop-Busui, R.
    Tang, Y.
    Shaw, H.
    Bueno, C. R.
    Sun, X.
    Mitri, J.
    Sambataro, M.
    Sambado, L.
    Gerstein, H. C.
    Fonseca, V.
    Doria, A.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S93 - S93
12345